FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

31571000087102: FLUZONE High-Dose Quadrivalent 60 micrograms per 0.7 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
157871000087119 Inf FLUZONE High-Dose Quadrivalent SP en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
157891000087115 FLUZONE High-Dose Quadrivalent 60 micrograms per 0.7 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
157901000087119 FLUZONE High-Dose Quadrivalent 60 micrograms per 0.7 milliliter suspension for injection Sanofi Pasteur Limited en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
161151000087117 Inf FLUZONE Haute Dose Quadrivalent SP fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Inf FLUZONE High-Dose Quadrivalent SP Has supplier Sanofi Pasteur Limited (supplier) true Inferred relationship Some
Inf FLUZONE High-Dose Quadrivalent SP Has ingredient qualitative strength dose élevée true Inferred relationship Some 4
Inf FLUZONE High-Dose Quadrivalent SP Has ingredient qualitative strength dose élevée true Inferred relationship Some 3
Inf FLUZONE High-Dose Quadrivalent SP Has ingredient qualitative strength dose élevée true Inferred relationship Some 2
Inf FLUZONE High-Dose Quadrivalent SP a une forme pharmaceutique (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
Inf FLUZONE High-Dose Quadrivalent SP a pour principe actif (attribut) Antigen of Influenza B virus Victoria lineage split virion (substance) true Inferred relationship Some 3
Inf FLUZONE High-Dose Quadrivalent SP Has product characteristic Unadjuvanted vaccine product (qualifier value) true Inferred relationship Some
Inf FLUZONE High-Dose Quadrivalent SP a pour principe actif (attribut) Antigen of Influenza B virus Yamagata lineage split virion true Inferred relationship Some 4
Inf FLUZONE High-Dose Quadrivalent SP a pour principe actif (attribut) Antigen of Influenza A virus subtype H1N1 split virion (substance) true Inferred relationship Some 1
Inf FLUZONE High-Dose Quadrivalent SP Has ingredient qualitative strength dose élevée true Inferred relationship Some 1
Inf FLUZONE High-Dose Quadrivalent SP a pour principe actif (attribut) Antigen of Influenza A virus subtype H3N2 split virion (substance) true Inferred relationship Some 2
Inf FLUZONE High-Dose Quadrivalent SP Plays role Active immunity stimulant role (role) true Inferred relationship Some
Inf FLUZONE High-Dose Quadrivalent SP est un(e) (attribut) Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage high dose each non-live antigen in parenteral dose form (medicinal product form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Administered tradename codes for vaccines reference set (foundation metadata concept)

Back to Start